Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Seitz-Polski

Showing results (71-80 of 78) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 78 results.
Kidney International|February 21, 2019
Novel ELISA for thrombospondin type 1 domain-containing 7A autoantibodies in membranous nephropathyChristelle Zaghrini, Barbara Seitz-Polski, Joana Justino, et al.
JAMA Dermatology|November 25, 2020
Clinical, Laboratory, and Interferon-Alpha Response Characteristics of Patients With Chilblain-like Lesions During the COVID-19 PandemicThomas Hubiche, Nathalie Cardot-Leccia, Florence Le Duff, et al.
Eclinicalmedicine|December 1, 2025
The personalized approach to rituximab treatment in membranous nephropathy: a multi-center randomized controlled trialVesna Brglez, Maxime Teisseyre, Kévin Zorzi, et al.
European Journal of Cancer (Oxford, England : 1990)|May 2, 2021
Severe acute respiratory syndrome coronavirus 2 vaccination for patients with solid cancer: Review and point of view of a French oncology intergroup (GCO, TNCD, UNICANCER)David Tougeron, Maxime Hentzien, Barbara Seitz-Polski, et al.
Bulletin Du Cancer|April 27, 2021
[Vaccination against COVID-19 in patients with solid cancer: Review and point of view from a French oncology inter-group (CGO, TNCD, UNICANCER)]David Tougeron, Barbara Seitz-Polski, Maxime Hentzien, et al.
Neurology|April 1, 2026
Diagnostic Value of the Kappa Free Light Chain Index to Distinguish MOGAD, NMOSD, and MSApolline Tournier, Antoine Gavoille, Julie Pique, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|November 14, 2022
Kappa Free Light Chain Biomarkers Are Efficient for the Diagnosis of Multiple Sclerosis: A Large Multicenter Cohort StudyMichael Levraut, Sabine Laurent-Chabalier, Xavier Ayrignac, et al.
Kidney International Reports|December 19, 2024
Anti Phospholipase A2 Receptor 1 Antibodies and Membranous Nephropathy Recurrence After Kidney TransplantationMarion Cremoni, Maxime Teisseyre, Olivier Thaunat, et al.
Pageof 8

Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
Kidney International|February 21, 2019
Novel ELISA for thrombospondin type 1 domain-containing 7A autoantibodies in membranous nephropathyChristelle Zaghrini, Barbara Seitz-Polski, Joana Justino, et al.
JAMA Dermatology|November 25, 2020
Clinical, Laboratory, and Interferon-Alpha Response Characteristics of Patients With Chilblain-like Lesions During the COVID-19 PandemicThomas Hubiche, Nathalie Cardot-Leccia, Florence Le Duff, et al.
Eclinicalmedicine|December 1, 2025
The personalized approach to rituximab treatment in membranous nephropathy: a multi-center randomized controlled trialVesna Brglez, Maxime Teisseyre, Kévin Zorzi, et al.
European Journal of Cancer (Oxford, England : 1990)|May 2, 2021
Severe acute respiratory syndrome coronavirus 2 vaccination for patients with solid cancer: Review and point of view of a French oncology intergroup (GCO, TNCD, UNICANCER)David Tougeron, Maxime Hentzien, Barbara Seitz-Polski, et al.
Bulletin Du Cancer|April 27, 2021
[Vaccination against COVID-19 in patients with solid cancer: Review and point of view from a French oncology inter-group (CGO, TNCD, UNICANCER)]David Tougeron, Barbara Seitz-Polski, Maxime Hentzien, et al.
Neurology|April 1, 2026
Diagnostic Value of the Kappa Free Light Chain Index to Distinguish MOGAD, NMOSD, and MSApolline Tournier, Antoine Gavoille, Julie Pique, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|November 14, 2022
Kappa Free Light Chain Biomarkers Are Efficient for the Diagnosis of Multiple Sclerosis: A Large Multicenter Cohort StudyMichael Levraut, Sabine Laurent-Chabalier, Xavier Ayrignac, et al.
Kidney International Reports|December 19, 2024
Anti Phospholipase A2 Receptor 1 Antibodies and Membranous Nephropathy Recurrence After Kidney TransplantationMarion Cremoni, Maxime Teisseyre, Olivier Thaunat, et al.
Pageof 8